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Purpose. Cardiomyocytes express IL-6 and its signal transducer, 130-kDa glyco-
protein (gp130) that inﬂ uence cell growth, apoptosis, diff erentiation and survival by 
an autocrine pathway. High levels of circulating IL-6 have been reported in patients 
with congestive heart failure (HF) and after myocardial infarction and IL-6-gp130-
signaling participates in HF prevention and compensatory hypertrophy, inﬂ uencing 
remodeling processes and inducing Protein kinase C (PKC)-dependent apoptosis. 
Recent studies demonstrated the presence of precursor cells able to diff erentiate into 
cardiomyocytes in the adult heart through signaling pathways similar to those in the 
embryonic heart thus participating to the physiologic repair of the injured heart. In 
this line, the study of the embryonic signaling may represent an important cue to 
understand the molecular bases of the regenerative capacity myocardial progenitors. 
Aim of this study was to investigate the signal transduction pathways evoked by IL-6 
treatment on cardiomyoblasts and its possible diff erentiating eff ects.
Methods. H9c2 cells cultured in medium supplemented with 1% FBS (diff erentia-
tion-promoting medium) in presence of IL-6 (10 ng/ml) up to three days.
Results. Western Blot and Immunoﬂ uorence analysis demonstrated that Il-6 after 
3 days of treatment induced a marked increase of the expression of α-myosin heavy 
chain (α-MHC; terminal cardiac diff erentiation marker) together with a microfi lament 
reorganization and morphological modifi cations, that included mono-nucleated cells 
elongation and fusion into multinucleated tubes. This process was accompanied by 
an evident nuclear translocation of Nkx2.5 (early myocardial development transcrip-
tion factor), and by a sub-cellular redistribution of gp130.
Results suggest that the biological eff ects evoked by IL6 were at least partially 
mediated by PI3K through Akt and PKCzeta pathways modulation, as confi rmed 
by the varied phosphorylated PI3K level observed after 30 min of IL-6 treatment 
and PI3K induction of downstream PKCzeta phosphorilation, but not PKCalpha and 
PKCdelta, whereas Akt de-phosphorylation was detected.
Conclusions. Our observations evidenced that PI3K is a key regulator of IL-6- 
induction of embryonic cardiomyocytes diff erentiation by PKCzeta and Akt-signal-
ling pathways. These data suggest a possible role of IL-6 dependent pathways in 
regenerative capacity of myocardial cells following injuries.
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